SK bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	242,839	312,702	127,026	225,287	98,028
Short-Term Investments	297,926	233,542	275,300	5,300	-0
Trading Asset Securities	556,007	611,864	871,816	1,250,218	1,547,635
Cash & Short-Term Investments	1,096,772	1,158,108	1,274,141	1,480,806	1,645,663
Cash Growth	-9.78%	-9.11%	-13.96%	-10.02%	-
Accounts Receivable	114,668	94,462	12,928	39,585	38,006
Other Receivables	14,763	93,934	9,414	50,076	10,129
Receivables	129,431	188,396	22,342	89,661	48,135
Inventory	196,620	211,126	80,649	187,406	135,046
Prepaid Expenses	7,901	5,748	1,613	1,649	1,407
Other Current Assets	5,318	13,295	4,224	24,173	7,554
Total Current Assets	1,436,042	1,576,673	1,382,969	1,783,694	1,837,804
Property, Plant & Equipment	1,078,793	982,607	315,923	293,057	220,983
Long-Term Investments	18,595	22,357	42,729	1,500	21,610
Goodwill	58,820	57,436	-	-	-
Other Intangible Assets	57,352	56,084	14,178	6,299	3,973
Long-Term Deferred Tax Assets	149,431	108,135	59,219	21,370	10,242
Long-Term Deferred Charges	31,906	11,027	8,281	11,882	13,088
Other Long-Term Assets	23,518	29,277	29,140	24,129	2,422
Total Assets	2,854,457	2,843,596	1,852,439	2,141,931	2,110,123
Accounts Payable	25,314	17,818	3,370	11,053	63,812
Accrued Expenses	57,325	54,298	19,716	30,242	26,322
Short-Term Debt	-	-	-	45,550	11,671
Current Portion of Long-Term Debt	-	-	-	38,008	47,978
Current Portion of Leases	4,794	6,957	8,137	12,235	2,309
Current Income Taxes Payable	1,815	6,994	-	20,216	101,486
Other Current Liabilities	231,143	224,523	104,397	222,733	206,374
Total Current Liabilities	320,390	310,589	135,620	380,037	459,952
Long-Term Debt	395,942	383,331	-	-	35,503
Long-Term Leases	1,375	2,526	12,436	17,543	8,775
Long-Term Deferred Tax Liabilities	72,882	71,960	-	-	-
Other Long-Term Liabilities	39,170	52,737	527.84	2,649	335.24
Total Liabilities	829,760	821,144	148,584	400,229	508,811
Common Stock	39,185	39,174	38,414	38,392	38,250
Additional Paid-In Capital	1,235,600	1,235,376	1,160,456	1,160,008	1,157,064
Retained Earnings	475,816	499,757	549,421	533,378	405,305
Comprehensive Income & Other	41,689	28,258	-44,435	9,924	692.92
Total Common Equity	1,792,290	1,802,565	1,703,855	1,741,702	1,601,312
Minority Interest	232,407	219,887	-	-	-
Shareholders' Equity	2,024,697	2,022,452	1,703,855	1,741,702	1,601,312
Total Liabilities & Equity	2,854,457	2,843,596	1,852,439	2,141,931	2,110,123
Total Debt	402,111	392,814	20,574	113,336	106,236
Net Cash (Debt)	694,661	765,294	1,253,568	1,367,469	1,539,428
Net Cash Growth	-37.76%	-38.95%	-8.33%	-11.17%	-
Net Cash Per Share	8909.76	9912.96	16277.20	17754.39	20850.38
Filing Date Shares Outstanding	78.37	78.35	76.83	76.78	76.5
Total Common Shares Outstanding	78.37	78.35	76.83	76.78	76.5
Working Capital	1,115,652	1,266,083	1,247,350	1,403,657	1,377,852
Book Value Per Share	22869.85	23007.37	22177.60	22683.12	20932.18
Tangible Book Value	1,676,119	1,689,045	1,689,678	1,735,403	1,597,339
Tangible Book Value Per Share	21387.48	21558.43	21993.06	22601.09	20880.24
Land	72,393	71,307	45,280	45,270	9,949
Buildings	427,694	425,887	124,315	127,741	119,990
Machinery	170,789	174,922	55,879	53,141	51,037
Construction In Progress	335,325	231,274	65,638	33,153	25,884

Source: S&P Global Market Intelligence. Standard template. Financial Sources.